HomeAREC • LON
add
Arecor Therapeutics PLC
Previous close
GBX 66.00
Day range
GBX 68.28 - GBX 68.28
Year range
GBX 35.40 - GBX 100.00
Market cap
25.78M GBP
Avg Volume
12.55K
P/E ratio
24.32
Dividend yield
-
Primary exchange
LON
Market news
The New York Times
12 hours ago
Stocks Extend ‘Astonishing’ Rally as Middle East Tensions Ease Further
1.20%
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.13M | 88.21% |
Total assets | 8.10M | -7.12% |
Total liabilities | 1.65M | -51.17% |
Total equity | 6.45M | — |
Shares outstanding | 37.76M | — |
Price to book | 3.88 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
44
